Poongjeon Pharmacy Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Public

  • Employees
  • 44

Employees

  • Stock Symbol
  • 298060

Stock Symbol

  • Investments
  • 5

  • Share Price
  • $1.69
  • (As of Friday Closing)

Poongjeon Pharmacy General Information

Description

Poongjeon Pharmacy Co Ltd, formerly SCM Lifescience Co Ltd is engaged in the research and development of medicines, hair care medicines, and stem cell products in South Korea.

Contact Information

Formerly Known As
SCM Lifescience
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 7-7, Gaetbeol-ro, 145beon-gil
  • Yeonsu-gu
  • Incheon, 21999
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
KRX
Vertical(s)
Corporate Office
  • 7-7, Gaetbeol-ro, 145beon-gil
  • Yeonsu-gu
  • Incheon, 21999
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Poongjeon Pharmacy Stock Performance

As of 20-Nov-2026, Poongjeon Pharmacy’s stock price is $1.69. Its current market cap is $18.3M with 10.8M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.69 $1.69 $1.50 - $4.04 $18.3M 10.8M 12.5K $0.07

Poongjeon Pharmacy Financials Summary

As of 31-Mar-2026, Poongjeon Pharmacy has a trailing 12-month revenue of $27M.

In Thousands,
USD
TTM 31-Mar-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 19,451 27,903 27,439 50,426
Revenue 27,008 16,751 604 532
EBITDA 1,300 1,027 (8,911) (17,512)
Net Income (64) 142 (9,071) (18,327)
Total Assets 33,579 36,107 15,730 19,713
Total Debt 4,386 3,842 4,730 2,963
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Poongjeon Pharmacy Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Poongjeon Pharmacy‘s full profile, request access.

Request a free trial

Poongjeon Pharmacy Patents

Poongjeon Pharmacy Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2025236785-A1 Method for mass-culturing mesenchymal stem cells Pending 11-Mar-2024
AU-2025237538-A1 Rapid layer-separation culturing method for mesenchymal stem cells Pending 11-Mar-2024
WO-2023243934-A1 Composition for preventing or treating arthritis comprising functionally enhanced stem cells Inactive 15-Jun-2022
CA-3225620-A1 Combined administration composition for preventing or treating atopic dermatitis, comprising function-enhanced stem cells and regulatory t cells Pending 01-Jun-2021
US-20240277772-A1 Combined administration composition for preventing or treating atopic dermatitis, comprising function-enhanced stem cells and regulatory t cells Pending 01-Jun-2021 A61K40/22
To view Poongjeon Pharmacy’s complete patent history, request access »

Poongjeon Pharmacy Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Poongjeon Pharmacy Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Poongjeon Pharmacy‘s full profile, request access.

Request a free trial

Poongjeon Pharmacy Investments & Acquisitions (5)

Poongjeon Pharmacy’s most recent deal was a Merger/Acquisition with Dermasimo for . The deal was made on 15-Sep-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Dermasimo 15-Sep-2025 Merger/Acquisition Internet Retail
Poongjeon Pharmaceutical 17-Jun-2025 Merger/Acquisition Distributors/Wholesale
Rocky Mountain (Manufacturing Facilities in Incheon, South Korea) 27-Mar-2025 Corporate Asset Purchase Buildings and Property
Vita Therapeutics 23-Jun-2021 Early Stage VC Drug Discovery
Argos Therapeutics 13-Feb-2019 Merger/Acquisition Drug Discovery
To view Poongjeon Pharmacy’s complete investments and acquisitions history, request access »

Poongjeon Pharmacy ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Poongjeon Pharmacy’s complete esg history, request access »

Poongjeon Pharmacy Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Argos Therapeutics Durham, NC 1997
Dermasimo Seoul, South Korea

Poongjeon Pharmacy FAQs

  • When was Poongjeon Pharmacy founded?

    Poongjeon Pharmacy was founded in 2014.

  • Where is Poongjeon Pharmacy headquartered?

    Poongjeon Pharmacy is headquartered in Incheon, South Korea.

  • What is the size of Poongjeon Pharmacy?

    Poongjeon Pharmacy has 44 total employees.

  • What industry is Poongjeon Pharmacy in?

    Poongjeon Pharmacy’s primary industry is Drug Discovery.

  • Is Poongjeon Pharmacy a private or public company?

    Poongjeon Pharmacy is a Public company.

  • What is Poongjeon Pharmacy’s stock symbol?

    The ticker symbol for Poongjeon Pharmacy is 298060.

  • What is the current stock price of Poongjeon Pharmacy?

    As of 20-Nov-2026 the stock price of Poongjeon Pharmacy is $1.69.

  • What is the current market cap of Poongjeon Pharmacy?

    The current market capitalization of Poongjeon Pharmacy is $18.3M.

  • What is Poongjeon Pharmacy’s current revenue?

    The trailing twelve month revenue for Poongjeon Pharmacy is $27M.

  • What is Poongjeon Pharmacy’s annual earnings per share (EPS)?

    Poongjeon Pharmacy’s EPS for 12 months was $0.07.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process